What is On-Site Home Hemodialysis?
Opportunity For A More Patient-Centric Approach
Prevalence of End-Stage Renal Disease (ESRD) in Skilled Nursing Facilities


On-Site Home Hemodialysis - A Better Care Model
Benefits of On-Site Home Hemodialysis
For patients who may not be able to tolerate abrupt hemodynamic changes often associated with conventional hemodialysis three times per week, on-site home hemodialysis offers individualized treatment options, including more frequent therapy when medically necessary.
Designed for Success

NxStage offers the following advantages compared to traditional in-center equipment:
- Compact design and small treatment space provide flexible treatment options in either bedside or den settings
- Simple user interface
- Minimal changes required to existing plumbing and electrical wiring
- Water purification system eliminates need for RO water treatment
- Most prescribed home hemodialysis machine in the US
Resource Center
Join the growing movement.
Despite the health benefits that more frequent home hemodialysis may provide to those with chronic kidney disease, this form of therapy is not for everyone.
The reported benefits of home hemodialysis may not be experienced by all patients.
The NxStage System One is a prescription device and, like all medical devices, involves some risks. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream, and blood loss due to clotting or accidental disconnection of the blood tubing set. When vascular access is exposed to more frequent use, infection of the site, and other access related complications may also be potential risks. Patients should consult with their doctor to understand the risks and responsibilities of home and/or more frequent hemodialysis using the NxStage System One.
Patients and providers are encouraged to contact their state regulators to discuss state-specific regulations that may impact dialysis in the Skilled Nursing Facility setting.
References:
- U.S. Renal Data System, USRDS 2016 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2016.
- DialysisData.org. FY2017 Dialysis Facility Report Data.
- Data on File. NxStage Medical, Inc. Health Advances Interviews. May 2013.
- Data on file. NxStage Medical, Inc. 2017 ADC Abstract on Medicare Payments for Transportation Between Nursing Institutions and Dialysis Facilities. March 2017.
- Weinhandl ED, Lie J, Gilbertson DT, Arneson TJ, Collins AJ. Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol. 2012;23(5):895-904.
- Yang A, Lee WY, Hocking K, Xelay Acumen, Inc., Affiliated Dialysis. Survival comparison of daily home hemodialysis vs conventional dialysis in the nursing home setting. Nephrol News Issues. 2015;29(2):25-27, 30-31.
- Bednar B. Improving Kidney Care for Residents in Nursing Facilities: A National Model. Nephrol News Issues. 2016:30-34.
- Jaber BL, Lee Y, Collins AJ, et al. Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics, and Everyday Dialysis Outcome Measurements) Stud. Am J Kidney Dis. 2010;56(3):531-539.
- Spanner E, Suri R, Heidenheim AP, Lindsay RM. The impact of quotidian hemodialysis on nutrition. Am J Kidney Dis. 2003;42(1 suppl):30-35.
- Jefferies et.al. Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (Myocardial stunning). Clin J Am Soc Neprhol. 2011 June, 6(6); 1326-1332.
- Jaber BL, Schiller B, Burkart JM, et al. Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances. Clin J Am Soc Nephrol. 2011;6(5):1049-1056.
- FHN Trial Group. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363(24): 2287-2300.
- Jaber BL, Collins AJ, Finkelstein FO, et al. Daily hemodialysis (DHD) reduces the need for antihypertensive medications. Abstract presented at American Society of Nephrology Conference, October 29, 2009.
- Kraus M, Finkelstein FO, Daoui R, et al. Short Daily Hemodialysis (SDHD) improves overall Quality of Life (QOL) and physical intimacy: interim results from the FREEDOM study. Abstract presented at the American Society of Nephrology Conference, 2011.
- Data on file. NxStage Medical, Inc. 2017.